Lake Bleu Capital is a Hong Kong-based multi-billion dollar asset management platform specializing in healthcare investing across Asia, with a primary focus on Greater China. The firm invests in both public equity and private equity mid-to-late-stage healthcare opportunities.
42% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $128.9M (across 30 rounds with reported amounts).
Portfolio
28
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
MS
Michael Sun
Partner
TD
Tony Ding
Director
AL
Amanda Li
Investment Professional
BL
Bin Li 李彬
Founder and Chief Investment Officer
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
38 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 SanegeneBio | Series B | $110M | Jan 2026 |
| SanegeneBio | Series B | $110M | Jan 2025 |
 瀚辰光翼 | Unknown | — | Jan 2023 |
| HHC Scientific | Series B | $41M | Jan 2023 |
| RRaynovent | Series C | — | Dec 2022 |
| RRecBio | Ipo | $227M | Jan 2022 |
| GGenFleet | Series C | $75M | Dec 2021 |
 Broncus | Ipo | $215M | Sep 2021 |
| LLupeng Pharmaceutical | Unknown | $35M | Jul 2021 |
 Exegenesis Bio | Series B | $50M | Jun 2021 |
 Insilico Medicine | Series C | $255M | Jun 2021 |
 Insilico Medicine | Series C | $255M | Jun 2021 |
 Abbisko | Series D | $123M | Jan 2021 |
| 和和誉生物 | Series D | $123M | Jan 2021 |
| AAbbisko Therapeutics | Series D | $123M | Jan 2021 |
| RRecBio | Series C | $158M | Jan 2021 |
| HHC Scientific | Series B | — | Jan 2021 |
| MMabworks Biotech | Series C | — | Apr 2020 |
 MicroPort | Unknown | $130M | Apr 2020 |
 RemeGen | Growth | $100M | Apr 2020 |
| RemeGen | Unknown | $100M | Apr 2020 |
| GGenFleet | Series B | — | Mar 2020 |
| RemeGen | Unknown | $100M | Jan 2020 |
| Broncus | Series C | — | Jan 2020 |
| GGenFleet | Series B | $50M | Jan 2020 |
Page 1 of 2
Top Co-Investors
OrbiMed13 shared
LAV11 shared
Legend Capital9 shared
Vivo Capital6 shared
Warburg Pincus LLC6 shared
Loyal Valley Capital5 shared
Sinovation Ventures5 shared
CPE5 shared
CDH Investments5 shared
Hudson Bay Capital Management4 shared
Baidu Ventures4 shared
Eight Roads4 shared
HongShan4 shared
LYFE Capital4 shared
BioTrack Capital4 shared
Mirae Asset3 shared
Bold Capital Partners3 shared
B Capital3 shared
Deerfield3 shared
Last updated: 7 October 2026